Nextki 70mg Tablet
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Dasatinib (70mg)
Overview Nextki 70mg Tablet
Chronic myeloid leukemia (CML) patients whose condition hasn't responded to or is unsuitable for other treatments may benefit from 70mg Nextki tablets. This medication can be administered with or without food, but consistent daily timing optimizes effectiveness. Dosage and frequency are determined by your physician based on individual needs and may adjust over time. Strict adherence to your doctor's prescription is crucial; incorrect usage or overdose can lead to severe adverse effects. While therapeutic effects may take weeks or months to manifest, discontinuation should only occur under medical supervision. Common side effects include nausea, vomiting, abdominal pain, and rash; less frequent but serious side effects may include altered heart rate and blood pressure fluctuations, necessitating immediate medical consultation. Regular blood pressure monitoring is often recommended. Antacids should be avoided within two hours of administration. Nextki can lower blood cell counts, increasing infection risk, mandating routine blood tests. Inform your healthcare provider of all other medications as interactions may occur. This medication is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or blurred vision develops.
Primary Ingredients of Nextki 70mg Tablet
No text provided to rephrase.
Uses of Nextki 70mg Tablet
Chronic myelogenous leukemia
Major Benefits of Nextki 70mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nextki 70mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Nextki 70mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Nextki 70mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Nextki 70mg Tablets can be administered with or without food, although consistent timing is recommended.
How Nextki 70mg Tablet works:
Oncaspar 70mg tablets are an anticancer drug. Their mechanism involves inhibiting the activity of a mutated protein responsible for triggering cancerous cell proliferation, thereby hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Nextki 70mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Employing Nextki 70mg tablets during pregnancy is contraindicated due to established harm to the fetus. Exceptions may exist in critical circumstances where a physician deems the potential advantages outweigh the risks. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Nextki 70mg tablets while breastfeeding is contraindicated. Available evidence indicates potential infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Nextki 70mg Tablet side effects. Exercise caution while driving if you experience dizziness or blurred vision after taking Nextki 70mg Tablet.
KidneySAFE IF PRESCRIBED
Nextki 70mg tablets are likely safe for individuals with kidney disease. Current evidence indicates dose modification may not be necessary, but physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Nextki 70mg tablets pose no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Nextki 70mg Tablet :
Omit any missed Nextki 70mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Nextki 70mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavioral Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently